Notably, SP5’s association with the activation of the AKT/mTOR signal pathway in prostate cancer [39], hints at intriguing regulatory mechanisms governing SERPING1 transcription that warrant further investigation. This evidence concerns the gene SP5 and prostate carcinoma.